DUBLIN, April 1, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/vn485q/testosterone) has announced the addition of the "Testosterone Replacement Therapy (TRT) - Global Strategic Business Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The Global and the US markets are analyzed by the following Product Segments: Topicals, Patches, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 35 companies including many key and niche players such as:
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. COMPETITION
4. AN OVERVIEW OF SELECT DRUGS ON THE MARKET
5. TESTOSTERONE DEFICIENCY AND TRT - AN OVERVIEW
6. PRODUCT LAUNCHES/APPROVALS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 35 (including Divisions/Subsidiaries - 36)
For more information visit http://www.researchandmarkets.com/research/vn485q/testosterone
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article